Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Publication | Open Access

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

DOI Full Paper Access

285

Citations

References

2022

Year

Byeong‐Keuk Kim, Sung‐Jin Hong, Yong‐Joon Lee, Soon Jun Hong, Kyeong Ho Yun, Bum‐Kee Hong, Jung Ho Heo, Seung‐Woon Rha, Yun‐Hyeong Cho, Seung‐Jun Lee,

The Lancet

Abstract

References